Close

Roth Capital Starts Catalyst Pharmaceutical Partners (CPRX) at Buy

June 17, 2011 10:53 AM EDT
Get Alerts CPRX Hot Sheet
Price: $1.12 -5.08%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Roth Capital initiates coverage on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) with a Buy. PT $4.

For more ratings news on Catalyst Pharmaceutical Partners click here and for the rating history of Catalyst Pharmaceutical Partners click here.

Shares of Catalyst Pharmaceutical Partners closed at $1.78 yesterday.


GET THE HOTTEST RESEARCH CALLS ON THE STREET- FREE TRIAL!





Related Categories

New Coverage

Related Entities

Roth Capital